William E. Gooding

24.3k total citations · 5 hit papers
283 papers, 17.2k citations indexed

About

William E. Gooding is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, William E. Gooding has authored 283 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Oncology, 93 papers in Pulmonary and Respiratory Medicine and 81 papers in Molecular Biology. Recurrent topics in William E. Gooding's work include Lung Cancer Treatments and Mutations (56 papers), Immunotherapy and Immune Responses (50 papers) and Head and Neck Cancer Studies (45 papers). William E. Gooding is often cited by papers focused on Lung Cancer Treatments and Mutations (56 papers), Immunotherapy and Immune Responses (50 papers) and Head and Neck Cancer Studies (45 papers). William E. Gooding collaborates with scholars based in United States, Germany and Slovakia. William E. Gooding's co-authors include Theresa L. Whiteside, Robert L. Ferris, Jennifer R. Grandis, Jonas T. Johnson, James D. Luketich, Sichuan Xi, Thomas K. Hoffmann, Stephanie D. Drenning, Rodney J. Landreneau and Tony E. Godfrey and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

William E. Gooding

281 papers receiving 16.9k citations

Hit Papers

Levels of TGF-α and EGFR Protein in Head and Neck Squamou... 1998 2026 2007 2016 1998 2017 2014 2015 2018 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
    1998 913 citations Jennifer R. Grandis, William E. Gooding et al. profile →
  2. Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients
    2017 511 citations Marie‐Nicole Theodoraki, Saigopalakrishna S. Yerneni et al. Clinical Cancer Research profile →
  3. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay
    2014 374 citations Simion I. Chiosea, Robert L. Ferris et al. profile →
  4. Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology
    2015 292 citations Simion I. Chiosea, Robert L. Ferris et al. profile →
  5. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules
    2018 262 citations Marina N. Nikiforova, William E. Gooding et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William E. Gooding United States 75 7.4k 5.0k 4.3k 4.1k 3.1k 283 17.2k
Ezra E.W. Cohen United States 67 8.5k 1.1× 4.7k 0.9× 5.6k 1.3× 1.7k 0.4× 3.2k 1.0× 421 16.9k
Luc G.T. Morris United States 57 4.5k 0.6× 3.0k 0.6× 2.2k 0.5× 1.3k 0.3× 3.6k 1.2× 221 12.1k
Joseph A. Califano United States 73 5.6k 0.8× 9.2k 1.8× 2.5k 0.6× 1.5k 0.4× 3.6k 1.2× 357 18.9k
Barbara Burtness United States 56 8.5k 1.1× 4.4k 0.9× 5.0k 1.2× 2.0k 0.5× 3.7k 1.2× 363 16.0k
Christine H. Chung United States 52 5.6k 0.8× 4.7k 0.9× 3.6k 0.8× 1.2k 0.3× 4.5k 1.4× 255 15.6k
Jennifer R. Grandis United States 75 10.5k 1.4× 10.6k 2.1× 5.0k 1.2× 2.6k 0.6× 3.1k 1.0× 342 23.4k
Robert L. Ferris United States 90 13.5k 1.8× 6.6k 1.3× 4.8k 1.1× 7.6k 1.9× 7.1k 2.3× 556 28.7k
Roger A’Hern United Kingdom 75 9.4k 1.3× 3.7k 0.7× 5.2k 1.2× 905 0.2× 4.0k 1.3× 282 20.5k
Bhuvanesh Singh United States 59 5.7k 0.8× 4.8k 1.0× 4.7k 1.1× 534 0.1× 3.2k 1.0× 169 13.6k
Gregory T. Wolf United States 70 8.2k 1.1× 4.2k 0.8× 5.4k 1.2× 1.4k 0.3× 7.9k 2.5× 343 20.9k

Countries citing papers authored by William E. Gooding

Since Specialization
Citations

This map shows the geographic impact of William E. Gooding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Gooding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Gooding more than expected).

Fields of papers citing papers by William E. Gooding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Gooding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Gooding. The network helps show where William E. Gooding may publish in the future.

Co-authorship network of co-authors of William E. Gooding

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Gooding. A scholar is included among the top collaborators of William E. Gooding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Gooding. William E. Gooding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Theodoraki, Marie‐Nicole, Saigopalakrishna S. Yerneni, Thomas K. Hoffmann, William E. Gooding, & Theresa L. Whiteside. (2017). Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients. Clinical Cancer Research. 24(4). 896–905. 511 indexed citations breakdown →
2.
Kansy, Benjamin, Fernando Concha‐Benavente, Raghvendra M. Srivastava, et al.. (2017). PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer. Cancer Research. 77(22). 6353–6364. 174 indexed citations
3.
Peyser, Noah D., Lin Wang, Yan Zeng, et al.. (2016). STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell Carcinoma. Cancer Prevention Research. 9(8). 657–663. 11 indexed citations
4.
Schuler, Patrick J., Malgorzata Harasymczuk, Carmen Visús, et al.. (2014). Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer. Clinical Cancer Research. 20(9). 2433–2444. 120 indexed citations
5.
Gross, Neil D., Julie E. Bauman, William E. Gooding, et al.. (2014). Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer. Clinical Cancer Research. 20(12). 3289–3298. 39 indexed citations
6.
Li, Hua, William E. Gooding, Levi A. Garraway, et al.. (2014). Genomic Analysis of Head and Neck Squamous Cell Carcinoma Cell Lines and Human Tumors: A Rational Approach to Preclinical Model Selection. Molecular Cancer Research. 12(4). 571–582. 91 indexed citations
7.
Srivastava, Rahul, Steve Lee, Pedro A. Andrade Filho, et al.. (2013). Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen–Specific T-cell Immunity in Head and Neck Cancer Patients. Clinical Cancer Research. 19(7). 1858–1872. 246 indexed citations
8.
Sen, Malabika, Sonali Joyce, Changyou Li, et al.. (2012). Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer. Clinical Cancer Research. 18(18). 4986–4996. 128 indexed citations
9.
Czystowska, Malgorzata, William E. Gooding, Mirosław J. Szczepański, et al.. (2012). The Immune Signature of CD8+CCR7+ T Cells in the Peripheral Circulation Associates with Disease Recurrence in Patients with HNSCC. Clinical Cancer Research. 19(4). 889–899. 36 indexed citations
10.
Taylor, Jennifer L., et al.. (2012). Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells. Cancer Research. 72(13). 3196–3206. 43 indexed citations
11.
Vaezi, Alec, Shama Buch, William E. Gooding, et al.. (2011). XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research. 17(16). 5513–5522. 42 indexed citations
12.
Argiris, Athanassios, Michalis V. Karamouzis, William E. Gooding, et al.. (2011). Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer. Journal of Clinical Oncology. 29(9). 1140–1145. 84 indexed citations
13.
Stabile, Laura P., et al.. (2011). Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells. Clinical Cancer Research. 17(13). 4425–4438. 97 indexed citations
14.
Ferris, Robert L., Liqiang Xi, Raja R. Seethala, et al.. (2011). Intraoperative qRT-PCR for Detection of Lymph Node Metastasis in Head and Neck Cancer. Clinical Cancer Research. 17(7). 1858–1866. 48 indexed citations
15.
Bandla, Santhoshi, Zhongren Zhou, William E. Gooding, et al.. (2011). Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma. Clinical Cancer Research. 17(13). 4513–4522. 48 indexed citations
16.
Lai, Stephen Y., Priya Koppikar, Sufi M. Thomas, et al.. (2009). Intratumoral Epidermal Growth Factor Receptor Antisense DNA Therapy in Head and Neck Cancer: First Human Application and Potential Antitumor Mechanisms. Journal of Clinical Oncology. 27(8). 1235–1242. 46 indexed citations
17.
Zhang, Weiping, Neil E. Bhola, Shailaja Kalyankrishna, et al.. (2008). Kinin B2 Receptor Mediates Induction of Cyclooxygenase-2 and Is Overexpressed in Head and Neck Squamous Cell Carcinomas. Molecular Cancer Research. 6(12). 1946–1956. 30 indexed citations
18.
López‐Albaitero, Andrés, Jayakar V. Nayak, Takeshi Ogino, et al.. (2006). Role of Antigen-Processing Machinery in the In Vitro Resistance of Squamous Cell Carcinoma of the Head and Neck Cells to Recognition by CTL. The Journal of Immunology. 176(6). 3402–3409. 127 indexed citations
19.
Xi, Liqiang, Virginia R. Litle, Siva Raja, et al.. (2006). A Combination of Molecular Markers Accurately Detects Lymph Node Metastasis in Non–Small Cell Lung Cancer Patients. Clinical Cancer Research. 12(8). 2484–2491. 41 indexed citations
20.
Ferris, Robert L., Liqiang Xi, Siva Raja, et al.. (2005). Molecular Staging of Cervical Lymph Nodes in Squamous Cell Carcinoma of the Head and Neck. Cancer Research. 65(6). 2147–2156. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ezra E.W. Cohen Breakdown of academic impact, for papers by Luc G.T. Morris Breakdown of academic impact, for papers by Joseph A. Califano Breakdown of academic impact, for papers by Barbara Burtness Breakdown of academic impact, for papers by Christine H. Chung Breakdown of academic impact, for papers by Jennifer R. Grandis Breakdown of academic impact, for papers by Robert L. Ferris Breakdown of academic impact, for papers by Roger A’Hern Breakdown of academic impact, for papers by Bhuvanesh Singh Breakdown of academic impact, for papers by Gregory T. Wolf
Rankless by CCL
2026